ABSTRACT: Th e use of prosthetic mesh for the tension-free repair of incisional hernias has been shown to be more eff ective than primary suture repair. Unfortunately, prosthetic materials can be a suboptimal choice in a variety of clinical scenarios. In general, prosthetic materials should not be implanted into sites with known contamination or infection because they lack an endogenous vascular network and are thus incapable of clearing bacteria. Th is is of particular relevance to the repair of recurrent hernias, which are often refractory to repair because of indolent bacterial colonization that weakens the site and retards appropriate healing. Although fascia lata grafts and muscle fl aps can be employed for tension-free hernia repairs, they carry the potential for signifi cant donor site morbidity. Recently, a growing number of clinicians have used human acellular dermal matrix as a graft material for the tension-free repair of ventral hernias. Th is material has been shown to become revascularized in both animal and human subjects. Once repopulated with a vascular network, this graft material is theoretically capable of clearing bacteria, a property not found in prosthetic graft materials. Unlike autologous materials such as fascial grafts and muscle fl aps, acellular dermal matrix can be used without subjecting the patient to additional morbidity in the form of donor site complications. Th is article presents a thorough review of the current literature, describing the properties of human acellular dermal matrix and discussing both animal and human studies of its clinical performance. In addition to the review of previously published clinical experiences, we discuss our own preliminary results with the use of acellular dermal matrix for ventral hernia repair in 46 patients.
postoperative wound infection rises to over 40%. In addition, Rodgers et al.¹² have noted that the implantation of synthetic nonabsorbable prostheses into the diaphragm and abdominal wall leads to encapsulation and large fi brotic conglomerates, which can be a nidus for infection.
In addition to their inability to clear infection, synthetic materials have been associated with serious complications such as adhesion formation, bleeding, fi stulae, erosion, and seroma formation in as many as 15% of cases.¹³,¹⁴ Surgeons must consider not only possible contraindications for the use of synthetics, but also the fact that failure and the need to explant these materials may render the hernia larger and harder to repair in the future. Despite these drawbacks, reconstruction with prosthetic materials continues to be the most common technique employed.¹⁵ Given the ease of use, abundant availability, perceived low cost, and familiarity with these materials, this trend is likely to continue until a better solution is proven.
Angiogenesis is recognized as an essential step in wound healing.¹⁶ Tissue that is vascularized is clearly more capable of resisting infection than synthetic materials. Vascularity allows tissue to resist or fi ght infection by delivering infl ammatory cells as well as nutrients and oxygen. Synthetic graft materials cannot elicit angiogenesis or produce growth factors and are therefore plagued by an inability to clear infection. Once they are infected, synthetic materials should be removed. Accordingly, the use of autologous tissue in the form of muscle fl aps, myocutaneous fl aps, fascial grafts, or de-epithelialized dermal grafts traditionally has been favored over synthetic graft materials when there is concern for infection. Using a rabbit model, Disa et al.¹⁷ demonstrated that free autologous fascia lata grafts retain their native cellular architecture and become vascularized when used for the repair of abdominal wall defects. Furthermore, they demonstrated that these fascial grafts were more capable than synthetic mesh of resisting infection. However, the use of autologous tissue in the form of muscle fl aps, myocutaneous fl aps, or fascial grafts may result in signifi cant donor site morbidity in the form of pain, seroma, hematoma, wound dehiscence,
INTRODUCTION
Restoring abdominal wall integrity is a challenging problem faced by surgeons. Defi ciencies of the abdominal wall can be the result of infection, abdominal compartment syndrome, trauma, or primary herniation. Th e resultant defects include the loss of skin, muscle, and/or fascia in varying combinations and degrees. Of the causes of abdominal wall defects, incisional hernia is the most common, with incidences as high as 11-20% of patients post-laparotomy.¹-³ When the primary repair of incisional hernias fail, the surgeon faces an increasingly diffi cult task as each subsequent attempt to repair becomes less likely to persist. Luijendijk et al.⁴ demonstrated the advantages of a tension-free technique in a study comparing suture repair of incisional hernias to the interpositional placement of synthetic mesh. Nonetheless, while several large studies have reported recurrence rates near 50% for primary suture repair,⁵-⁷ others have noted a rate of recurrence as high as 34% for those repairs done with synthetic mesh.⁸-¹⁰ Although the use of synthetic materials may decrease reherniation rates, there are many clinical situations in which the use of these materials is illadvised. Th ese situations include, but are not limited to, enterocutaneous fi stulae, recent intra-abdominal infections, sites with previous wound infections, areas with unstable wound coverage, operative fi elds in which an ostomy will be located near the suture line, and in patients who are immunocompromised. Furthermore, it has been demonstrated that patients with incisional hernias, as a group, have higher rates of postoperative wound infections, even when their previous incision sites appear to have healed completely without signs of infection. Specifi cally, Houck et al.¹¹ found that patients undergoing abdominal hernia repair had a postoperative wound infection rate of 16%, compared to an infection rate of 1.5% for patients undergoing other "clean" procedures. Th e authors suggest that subclinical bacterial contamination may play a signifi cant role in the development of the initial hernia. When hernias are repaired at the site of a previously documented infection, the rate of and lateral knee instability from the disruption of the ilio-tibial tract. Autologous tissues are not always available in suffi cient quantity, and their use can greatly increase operative times and complexity and are generally outside the scope of practice of many general surgeons.¹⁸-²³ Similarly, the component separation technique generally allows the surgeon to close a defect with local autologous tissue but necessitates extensive dissection and is not always suffi cient when the repair is located near an ostomy or when the operative fi eld contains severe scarring from previous procedures.²⁴ As a result of the inherent drawbacks of synthetic and autologous graft materials, signifi cant eff ort has been spent on the identifi cation of new techniques and materials for use in hernia repair. Among the biological materials investigated, several have been produced from animal sources. Th ese xenogenic materials, including porcine small intestinal submucosa, even when rid of cells, are prone to immunologic rejection over time.²⁵ Xenogenic acellular dermal matrix (XADM) implants also have been studied in an animal model and were shown to elicit a chronic humoral and cell-mediated immune response that resulted in poor wound healing when compared to allogenic tissue.²⁶ Recently, human acellular dermal matrix (HADM) has been used by surgeons for a number of aesthetic and reconstructive indications. Lauded initially for its ability to improve wound healing in burn patients, it has been used with great success for the repair of complex abdominal wall hernias.
HUMAN ACELLULAR DERMAL MATRIX
Human acellular dermal matrix (AlloDerm®, LifeCell, Branchburg, New Jersey) is processed from human cadaver skin obtained from AATB guidelinecompliant tissue banks. To limit the possibility of disease transmission, donors are rigorously screened by social and medical history. In addition, they undergo serological testing for RPR, VDRL, HBsAg, anti-HCV 2.0, anti-HIV-1 and 2, anti-HTLV-1, and bacterial and fungal organisms. Because it is an acellular product, HADM is also presumably incapable of transmitting Creutzfeldt-Jakob and other prion diseases. Furthermore, prion diseases have never been transmitted through skin; only neural tissues have been implicated in the transmission of these diseases.
Partial-thickness sheets of skin are harvested from these cadavers using a dermatome. Because a dermatome is used to harvest the skin, commercially available sheets of AlloDerm® are available in pieces currently no larger than 4 × 16 cm. For defects larger than this, surgeons must suture two or more sheets of AlloDerm® together (see Fıgs. 1a-c). Th e manufacturer of AlloDerm® uses a proprietary method to separate the epidermis from the dermis, which employs a high-ionic-strength solution to uncouple the bonds between the layers. Sodium deoxycholate is then used to remove cells from the dermis. Th is process eliminates the potential for graft rejection mediated by host macrophages, fi broblasts, endothelial cells, dendritic cells, and Langerhans' cells. Th is same step simultaneously eradicates donor major histocompatibility class I and II antigens.²⁷ Th e acellular dermis is then freezedried by a unique proprietary method, which creates an amorphous ice that retains the structural integrity of the complex microarchitecture of the dermis. During conventional freeze-drying, hexagonal ice crystals form, disrupting the normal architecture of this layer and rendering the damaged matrix susceptible to infl ammation and rejection, because the hosts immune system regards the fragmented subunits as individual foreign bodies.
Th is three-step process ultimately yields a biomaterial containing a structurally intact basement membrane with overlying matrix. Th e remaining matrix contains glycosaminoglycans; intact human dermal collagen fi bers and bundles of types I, III, IV, and VII; and intact elastin and laminin.²⁸,²⁹ Th e normal dermal architecture supports angiogenesis and host cellular migration, while the collagen and elastin provide biomechanical strength.³⁰ HADM shares many favorable characteristics with other allograft materials. Like fascial grafts, HADM develops a vascular supply, a quality that allows the material to better resist infection. In addition, HADM is stronger than fascia and is as resistant to stretch and suture pull-through.³¹,³² Although HADM is an allograft material that becomes incorporated into and invested by native tissue, it has been shown to persist after implantation. In a study of the performance of HADM as a soft-tissue fi ller, Costantino et al.³³ demonstrated that 80-85% of this material had Our group has conducted two animal series to evaluate the performance of ADM for the repair of ventral hernias. Th e fi rst study, which used New Zealand White rabbits, was designed to compare the performance of human ADM to ePTFE (Micromesh®) implants.³⁵ In this study, all animals survived and none developed hernias. Fluorescein dye injection and histologic analysis confi rmed neovascularization of all ADM implants. Visceral adhesions to the graft were found in all of the animals repaired with Micromesh® but in none of the animals repaired primarily or with ADM. Th is fi nding is supported by the recently published data of Butler and Prieto.³⁶ In a study designed to evaluate the ability of HADM to prevent visceral adhesions, these researchers compared polypropylene grafts to polypropylene grafts married to sheets of HADM and found that the HADM prevented adhesions.
In our study, two of the ADM patches increased in size by 1 cm in the transverse dimension. Th is increase in width was found to be statistically insignifi cant (p = 0.17) when compared to the change in size of the ePTFE. Tensiometry testing revealed that the mean breaking strength of the primary closure group was signifi cantly higher than that of the two groups repaired with a patch. Th ere was, however, no signifi cant diff erence in breaking strength between the ADM/ fascia interface and the porous micromesh/fascia interface. Th is study was able to demonstrate that ADM becomes vascularized when implanted into the abdominal wall and has mechanical eff ectiveness similar to ePTFE (Micromesh®) but without the formation of visceral adhesions.
In order to follow the encouraging results of the rabbit study, our group performed a longer follow-up study in swine.³⁷ By using porcine ADM furnished by LifeCell Corporation, we were able to conduct a 9-month evaluation of the performance of ADM for repair of ventral hernias. Use of allogenic ADM allowed us to evaluate this material without the confounding eff ects of a xenogenic rejection of the implants. Using a similar study design we randomized 22 Yucatan miniature pigs to two groups. After creation of 12 × 4 cm full-thickness abdominal wall defects, the pigs were repaired with either homologous ADM (n = 12) or ePTFE (n = 10). Animals were terminated at either 3 or 9 months. At the time of termination, the surgical sites were evaluated for the presence of hernias. Th e grafts were then excised and evaluated for stretching of the implant, visceral adhesions, vascularity, and biomechanical strength.
Ultimately, two hernias developed with each material. However, minimal stretching or adhesion was found in any implant. Fluorescein dye testing and histologic analysis demonstrated vascular ingrowth within all ADM grafts. Tensiometry testing revealed no statistical diff erence in the mean breaking strength between the ADM/fascia interface (106.5 N ±SD 40.1), the ADM/ADM interface after suture removal (149.1 N ±SD 76.7), and primary fascial repair (108.1 N ±SD 20.9) at 9 months. Th e ADM/fascia interface, however, was found to be signifi cantly stronger than that of the ePTFE/fascia interface (66.1 N ±SD 30.1) (p = 0.017).
Clinical Experience
Previous to its use in abdominal wall reconstruction, ADM was used successfully for numerous reconstructive and aesthetic applications. It was fi rst used by Wainwright et al.³⁸ for the treatment of full thickness burns. Th ey found that the application of ADM between a well-debrided burn surface and a splitthickness skin graft lead to less contracture, as well as improved soft tissue volume and greater durability of the skin graft. Other early applications of HADM have included its use as a soft-tissue fi ller in aesthetic surgery³³,³⁹ for the correction of periodontal disease⁴⁰ and as a dural replacement in neurosurgery.⁴¹,⁴² More recently, HADM has been used by clinicians for repair of abdominal fascial defects. Surgeons have reported using HADM for indications such as TRAM fl ap donor site closure, ventral hernia repair (see Fıgs. 2a-e), and as a replacement for infected synthetic mesh. Operative techniques for the implantation of HADM range from interpositional grafts, onlay, sublay, and even interpositional graft material used in conjunction with the component separation technique.
Several groups have reported success with the use of HADM for abdominal wall reconstruction. Hirsch⁴³ has reported a case in which HADM was used to repair a large abdominal wall fascial defect in the setting of signifi cant local wound sepsis. Several days after this procedure, the patient developed a wound infection. Th e HADM graft was left in place even after the development of a frank enterocutaneous fi stula. Th is fi stula closed after several weeks of bowel rest, TPN, octreotide, and local wound care. Th is patient ultimately healed and was without evidence of hernia by physical examination at 3 and 6 months. At 9 months he had a CT scan, which failed to demonstrate a hernia, and at the time of publication, the patient had returned to work without disability.
Guy et al.⁴⁴ recently published their experience with the use of HADM for early one-stage closure of fascial defects resulting from abdominal compartment syndrome. Whereas the standard method of repair for these patients has historically required threestage closure, Guy's group was able to repair fascial defects with HADM and provide adequate coverage with bilateral bipedicle advancement fl aps. Using this technique, they were able to decrease greatly the length of hospitalization for these patients, as well as minimize the period in which patients have large and debilitating hernias while they await defi nitive repair. Although the patients profi led in this study were all trauma victims, several with frankly perforated viscus, complications were noted in only three of the nine patients and were limited to one fl ap hematoma, one recurrent hernia, and a wound infection that was cleared by drainage and local wound care. It is important that no patients developed postoperative fi stulae, and no patient required explantation of the HADM implant.
In 2004, Buinewicz and Rosen⁴⁵ published a retrospective review of their clinical experience using HADM to repair TRAM fl ap sites (n = 18), incisional hernias (n = 21), and abdominal wall defects of various etiologies (n = 5). Th eir series of 44 patients started with a single case in which a TRAM fl ap site herniated by the second postoperative week and was repaired with ePTFE. Intraoperative cultures revealed the presence of methicillin-resistant Staphylococcus aureus (MRSA), which persisted despite a 6-week course of Vancomycin therapy. Th is patient was ultimately repaired with HADM, and the surgeon elected not to reimplant synthetic graft material into the colonized site. Although the MRSA wound infection was an unforeseen complication, the incidence of TRAM fl ap harvest site hernias is known to be as high as 10% (Carlson, 1994) . After initial success with this patient, Buinewicz and Rosen⁴⁵ abandoned the use of synthetic graft material and began to use HADM preferentially for all patients. Th is proclivity for the use of HADM included clinical situations (n = 8) in which gross wound infection existed at the time of HADM implantation. Postoperative wound complications in this series included two patients with seroma, three patients with postoperative infection, and two with wound dehiscence. All of these patients were treated conservatively, and no patients graft required explantation. Furthermore, graft biopsies analysis of the graft biopsies showed areas defi cient in elastin. Th is was thought to represent an ongoing remodeling of the graft into tissue that resembled fascia histologically.
Our preliminary experience with the use of HADM for repair of abdominal wall defects consists of 49 repair sites in 46 patients. From November of 2001 to June of 2004, four surgeons in our division used HADM to repair a variety of defects. Although no absolute indications for the use of HADM have been identifi ed, this material generally has been selected as the implant material when there is either suspicion for, or incontrovertible evidence of, infection at the defect site. In addition, HADM was employed frequently when the patient was immunocompromised and/or deemed prone to poor wound healing (see Table 1 ). HADM was used in a variety of techniques, including as an interpositional graft and in a variety of tension-free methods (see Table 2 ). Demographic characteristics of the patients in our series include an average age of 51.8 years (range 18-71), a gender ratio of approximately two females to three males (18:28) , and an average body mass index (BMI) of 32.7 (range 18.1-58.5). Of the sites repaired, 20 were initial repairs, whereas 18 sites had had one previous repair, and the remaining 11 sites had had two or more previous repairs.
Ultimately, 11.9% of the sites reherniated (mean follow-up for all patients 184 days vs. 232 days for patients with reherniation). Seven patients either died or were lost to follow-up. Other complications included ten wound infections, of which only two were associated with reherniation and one lead to the explantation of the HADM. A second explantation was performed but was not associated with wound infection or reherniation (this patient became septic after surgery and the graft was removed empirically). Fıve sites had seroma, two of which required incision and drainage, two of which had one-time percutaneous aspiration, and one of which necessitated multiple percutaneous aspirations for resolution. None of the seromas were in sites that ultimately failed. One patient had an acute fascial dehiscence and was taken urgently to the operating room, where the HADM was covered with Marlex. Placement of HADM near a stoma was not associated with reherniation or wound complications. In general, the patients who reherniated were younger (42.6 years) and less obese (BMI = 24.8). It is interesting that no patients with reherniation were diabetic, and only one was an active smoker. Of the fi ve patients with documented reherniation, two were solid-organ transplant recipients on immune suppression regimens consisting of steroids, tacrolimus, and mycophenolate mofetil. 
CONCLUSIONS
Abdominal wall defects, including incisional hernias, are a common problem faced by the reconstructive and general surgeon. Tension-free repair using synthetic materials has been shown to provide a better long-term success rate than primary fascial repair. Th is improved success rate-however, is tempered by complications associated with the inability to resist and clear infection. Because many hernias are thought to recur as a result of indolent bacterial contamination, the use of synthetics can be a precarious option. Unlike synthetics, autologous tissues such as fascial grafts have the advantage of developing a native blood supply, which can participate in the host's eff orts to clear infection. Unfortunately, the use of autologous tissues is related to signifi cant potential cost in the form of donor site morbidity, time of harvest, and a generally limited supply. For patients prone to infec-tion and poor wound healing and in patients who are critically ill or metabolically taxed, the use of HADM will certainly reduce the stress currently associated with the harvest of autologous tissues. Like autologous tissues, HADM is well tolerated by the host immune system, has the capacity to revascularize and therefore clear infection, and has mechanical properties conducive to repairing fascial defects. Animal research demonstrates that HADM fuses with native fascia and develops a connection that is stronger than the connection between fascia and synthetic materials. Both animal and human data suggest that a large percentage of implanted ADM persists over time. Fınally, even in situations in which HADM does become contaminated by infection, clinical data suggest that because of its development of an endogenous vascular supply this material can be safely left in place and treated conservatively with local wound care and antibiotics. Our research group is currently conducting animal research to assess and quantify the ability of ADM to clear contamination caused by organisms commonly associated with wound infections.
Like all promising new materials and innovations, the theoretical advantages and early encouraging results of this material need to withstand the test of time. To that end, we look forward to reporting on the long-term performance of HADM.
